Malformations of cortical development (MCDs) represent a heterogeneous spectrum of disorders, characterized by abnormal development of the cerebral cortex. Many MCDs are of genetic origin, although acquired factors can lead to similar phenotypes. In this narrative review, we provide an overview of the diagnostic approach to MCD, illustrated with clinical vignettes.
Short course training, particularly in low-income settings, is rarely carefully evaluated. This study reports the findings, using a well-established evaluation framework, of 250 1-day paediatric epilepsy training courses delivered in 17 countries over 15 years. Participants conveyed high course satisfaction, demonstrated a significant improvement in knowledge after the course, and reported positive changes in clinical practice 6 months later.
Recently characterized immune-mediated central nervous system disorders include new antibodies causing previously recognized phenotypes.
Aggregation of conditions with similar clinical triggers, and characterization of unique imaging features in virus-associated encephalopathy syndromes.
Immune treatment iscurrently guided by meta-analysis of individualized patient data and/or multi-national consensus.
The immune-targeting of the central nervous system comprises of the innate and adaptive response. Recently characterised syndromes of dysregulation include virus associated encephalopathy syndrome and myelin-oligodendrocyte- glycoprotein associated disorders. The spectrum and treatment strategies are evolving for immune-mediated encephalitis.
Historically, many antenatal risk factors have been associated with optic nerve hypoplasia (ONH) and septo-optic dysplasia (SOD).
Population-based data with matched controls for potential confounding bias are lacking.
Young maternal age at conception, primigravida, and smoking during pregnancy are the main risk factors for ONH and SOD using a population-based, case–control design.
The burden of invasive group B streptococcal (GBS) infection in Norway is considerable.
Of GBS infection survivors, 20.7% were diagnosed with neurodevelopmental disorders (NDDs) at mean age 12 years 10 months.
Infants with GBS meningitis were more often diagnosed with NDDs.
Absolute risks associated with GBS infections were highest for pervasive and specific developmental disorder, cerebral palsy, and attention-deficit/hyperactivity disorder.
The burden of invasive group B streptococcus infection during infancy is considerable and continues to affect children beyond infancy. Novel preventive strategies for disease reduction, as well as systematic follow-up of survivors, is therefore needed.
This original article is commented on by Le Doare on pages 11–12 of this issue.
Please check your email for instructions on resetting your password.
If you do not receive an email within 10 minutes, your email address may not be registered,
and you may need to create a new Wiley Online Library account.
Request Username
Can't sign in? Forgot your username?
Enter your email address below and we will send you your username
If the address matches an existing account you will receive an email with instructions to retrieve your username